Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Novel Anti-cancer Agents and Cellular Targets and Their Mechanism(s) of Action
| Novel Anti-cancer Agents and Cellular Targets and Their Mechanism(s) of Action |
| Autore | Allison Simon J |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (206 p.) |
| Soggetto topico |
History of engineering & technology
Technology: general issues |
| Soggetto non controllato |
5-FU resistance
8-hydroxydaidzein affibody drug conjugate (AffiDC) affibody molecule albumin binding domain angiogenesis anti-cancer agent anticancer drug apoptosis AQ4N autophagy B-lactam steroid alkylators BCR-ABL biomarker bioprecursor breast cancer BxPC-3 c-myc cancer hallmarks CCN1 colorectal cancer Connectivity Map CYP1A1 CYP1B1 CYP2W1 Cytochrome P450 DM1 drug repurposing duocarmycin EGFR tyrosine kinase inhibitor emtansine expression gene silencing Genomics of Drug Sensitivity in Cancer glioblastoma HepG2 Huh7 human epidermal growth factor receptor 3 (HER3) hybrid steroidal alkylating agents in vivo imaging invasion isatin sulfonamides K562 MAPK mesenchymal-amoeboid transition microtubule acetylation migration molecular docking n/a nanoparticles nanosystems NF-κB oncogene ovarian cancer phortress photon upconversion PLGA poly (ADP-ribose) polymerase inhibitors prodrug RNA interference siRNA synthetic lethality triple-negative breast cancer triplet-triplet annihilation |
| ISBN | 3-0365-5222-7 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Novel Anti-cancer Agents and Cellular Targets and Their Mechanism |
| Record Nr. | UNINA-9910619465503321 |
Allison Simon J
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Small Cell Lung Cancer: A New Era Is Beginning?
| Small Cell Lung Cancer: A New Era Is Beginning? |
| Autore | Morabito Alessandro |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (150 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
atezolizumab
biology of SCLC chemotherapy circulating tumor cells DDR durvalumab extensive disease extensive-stage small cell lung cancer gene pathway ICB immune checkpoint inhibitors immune-checkpoint inhibitors in SCLC immunotherapy Immunotherapy ipilimumab lobectomy lurbinectedin multimodal treatment n/a nivolumab PARP pathobiology pathology and classification of SCLC pembrolizumab pneumonectomy prognostic biomarker radiotherapy SCLC SLFN11 small cell lung cancer small-cell lung cancer STING synthetic lethality targeted agents targeted therapy |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Small Cell Lung Cancer |
| Record Nr. | UNINA-9910557380603321 |
|
Morabito Alessandro
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||